CardiaLen, Inc. awarded SBIR Grant
CardiaLen Awarded Phase I SBIR Grant Cardiac arrhythmia start-up awarded $216,027 grant to develop a...
CardiaLen Awarded Phase I SBIR Grant Cardiac arrhythmia start-up awarded $216,027 grant to develop a...
CardiaLen receives significant financing from Broadview Ventures CardiaLen receives significant financing from Broadview Ventures to...
CardiAQ Valve Technologies (CVT) appoints Rob Michiels as Chief Executive Officer “As former President and...
CardiAQ Valve Technologies (“CVT”) to present latest in vivo results of its TranscatheterMitral Valve Implantation...
Santaris Pharma A/S and miRagen Therapeutics, Inc. Form Strategic Alliance to Develop microRNA-targeted Medicines for...
CardiAQ Valve Technologies (“CVT”) completes move of its headquarters to a specialized facility in Irvine,...